Coverage / ITRMF / Trade Card

ITRMF

Iterum Therapeutics PLC

AVOID 2026-08-20 Data 23 days old USD 0.02 Healthcare - Biotechnology
BLOCKED - NOT ACTIONABLEMethodology gate: frameworkRuleCheck
29

Position levels

Currenttoday
USD 0.02
Buy <=wait / entry
-
Trim >=take some off
-
Thesis breaknot set
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case8%100 / 1008.0
Base case48%62 / 10029.8
Bear case44%10 / 1004.4
Weighted conviction29 / 100 - AVOID

Top risks

  • Commercial contract with GPO tied to major U.S. PBM providing coverage for >40 million lives from early 2026
  • Japanese Patent Office Decision to Grant for sulopenem etzadroxil combination with projected expiry March 2041
  • High Court of Ireland order on March 27 2026 appointing Teneo Restructuring liquidators
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.